.

Publications & News

Title Download
Implantable CGM Use Improves Glycemic Control in CGM Naive Patients Media
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study Media
Ascensia Diabetes Care launches patient assistance program to provide broader access to Eversense Continuous Glucose Monitoring System Webcast
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance Media
The PROMISE Study: An Evaluation of the Safety and Accuracy of the Next Generation 180-Day Long-term Implantable Eversense CGM System Media
The PROMISE Study: An Evaluation of the Safety and Accuracy of the Next Generation 180-Day Long-term Implantable Eversense CGM System Media
2020 ATTD: Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor Over Multiple Sensor Insertion and Removal Cycles Media
2020 ATTD: Percent of Patients with Targeted Time in Range and Time in Hypoglycemia with the Eversense CGM System Media
2020 ATTD: Correlation Between Time in Range and Glucose Management Indicator with the Eversense CGM System Media
2020 ATTD: The Glycemic Outcomes of the Eversense CGM System in an Expanded Cohort of 582 Real-World US Commercial Users Media